secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0000950170-23-039037
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q2 revenue down 19% to $83.6M; net loss widens to $9.8M
--------------------------------------------------------------

- Total revenue $83.6M, down 19.1% YoY; GAAP net loss $9.8M vs $3.4M loss year ago.
- Adjusted net loss $5.8M; Adjusted EBITDA loss $3.2M (vs positive $3.2M in Q2 2022).
- Entered agreement to acquire Physio-Assist to add airway clearance market opportunity.
- Introduced Inogen Rove 6 portable oxygen concentrator with 8-year expected service life.
- Cash, cash equivalents and marketable securities $170.1M; no debt outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023039037/0000950170-23-039037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023039037/ingn-20230807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-039037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer